AT330360B - Verfahren zur herstellung eines pharmazeutischen praparates - Google Patents

Verfahren zur herstellung eines pharmazeutischen praparates

Info

Publication number
AT330360B
AT330360B AT151973A AT151973A AT330360B AT 330360 B AT330360 B AT 330360B AT 151973 A AT151973 A AT 151973A AT 151973 A AT151973 A AT 151973A AT 330360 B AT330360 B AT 330360B
Authority
AT
Austria
Prior art keywords
manufacturing
pharmaceutical preparation
pharmaceutical
preparation
Prior art date
Application number
AT151973A
Other languages
German (de)
English (en)
Other versions
ATA151973A (de
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ATA151973A publication Critical patent/ATA151973A/de
Application granted granted Critical
Publication of AT330360B publication Critical patent/AT330360B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
AT151973A 1972-02-22 1973-02-21 Verfahren zur herstellung eines pharmazeutischen praparates AT330360B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22792072A 1972-02-22 1972-02-22

Publications (2)

Publication Number Publication Date
ATA151973A ATA151973A (de) 1975-09-15
AT330360B true AT330360B (de) 1976-06-25

Family

ID=22854980

Family Applications (1)

Application Number Title Priority Date Filing Date
AT151973A AT330360B (de) 1972-02-22 1973-02-21 Verfahren zur herstellung eines pharmazeutischen praparates

Country Status (18)

Country Link
US (1) US3758679A (US07582779-20090901-C00044.png)
JP (1) JPS4896716A (US07582779-20090901-C00044.png)
AR (1) AR195704A1 (US07582779-20090901-C00044.png)
AT (1) AT330360B (US07582779-20090901-C00044.png)
AU (1) AU473502B2 (US07582779-20090901-C00044.png)
BE (1) BE795766A (US07582779-20090901-C00044.png)
CA (1) CA1016460A (US07582779-20090901-C00044.png)
DD (1) DD102302A5 (US07582779-20090901-C00044.png)
DE (1) DE2307747A1 (US07582779-20090901-C00044.png)
ES (1) ES411946A1 (US07582779-20090901-C00044.png)
FR (1) FR2181747B1 (US07582779-20090901-C00044.png)
GB (1) GB1390311A (US07582779-20090901-C00044.png)
HU (1) HU165913B (US07582779-20090901-C00044.png)
IE (1) IE37297B1 (US07582779-20090901-C00044.png)
IL (1) IL41527A (US07582779-20090901-C00044.png)
NL (1) NL7302385A (US07582779-20090901-C00044.png)
SE (1) SE382751B (US07582779-20090901-C00044.png)
ZA (1) ZA731154B (US07582779-20090901-C00044.png)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3830749A1 (de) * 1987-09-11 1989-03-30 Squibb & Sons Inc Arzneimittel in form von kuegelchen mit hohem arzneistoffgehalt und verfahren zu ihrer herstellung

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3922339A (en) * 1974-06-20 1975-11-25 Kv Pharm Co Sustained release medicant
US4167558A (en) 1976-02-13 1979-09-11 Hoffmann-La Roche Inc. Novel sustained release tablet formulations
GB1561204A (en) * 1977-06-01 1980-02-13 Ici Ltd Sustained release pharmaceutical composition
DE2923279B1 (de) * 1979-06-08 1980-11-20 Kali Chemie Pharma Gmbh Verfahren zur Herstellung von Pankreatin-Pellets
US4665100A (en) * 1981-03-13 1987-05-12 Eli Lilly And Company Process for formulating a synthetic drug for use in animal feed, and resulting formulation
JPS615027A (ja) * 1984-06-18 1986-01-10 Sadahiro Nakano 徐放性固形製剤
GB8518927D0 (en) * 1985-07-26 1985-09-04 Vincent Processes Ltd Tablets
US4940556A (en) * 1986-01-30 1990-07-10 Syntex (U.S.A.) Inc. Method of preparing long acting formulation
US5198226A (en) * 1986-01-30 1993-03-30 Syntex (U.S.A.) Inc. Long acting nicardipine hydrochloride formulation
IL81419A0 (en) * 1986-01-30 1987-08-31 Syntex Inc Long acting sustained release pharmaceutical compositions containing dihydropyridines and their preparation
US4855143A (en) * 1986-04-04 1989-08-08 Hans Lowey Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics
US4775535A (en) * 1986-04-04 1988-10-04 Hans Lowey Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics
DE3612211A1 (de) * 1986-04-11 1987-10-15 Basf Ag Kontinuierliches verfahren zum tablettieren
GB8624213D0 (en) * 1986-10-09 1986-11-12 Sandoz Canada Inc Sustained release pharmaceutical compositions
US5443764A (en) * 1987-07-01 1995-08-22 Ici Australia Operations Propietary Limited Water-dispersible granules
US4973470A (en) * 1989-06-26 1990-11-27 Warner-Lambert Company Sustained release pharmaceutical compositions
JP3623805B2 (ja) * 1992-02-20 2005-02-23 ユーロセルテイツク・エス・アー ヒドロモルホンスフェロイド調整放出製剤
GB9203689D0 (en) * 1992-02-20 1992-04-08 Euro Celtique Sa Pharmaceutical composition
US5837292A (en) * 1996-07-03 1998-11-17 Yamanouchi Europe B.V. Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug
GB2418854B (en) * 2004-08-31 2009-12-23 Euro Celtique Sa Multiparticulates
US20080057122A1 (en) * 2006-08-31 2008-03-06 Aaipharma Inc. Acetaminophen pharmaceutical compositions

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3830749A1 (de) * 1987-09-11 1989-03-30 Squibb & Sons Inc Arzneimittel in form von kuegelchen mit hohem arzneistoffgehalt und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
IL41527A (en) 1975-12-31
ES411946A1 (es) 1976-05-01
SE382751B (sv) 1976-02-16
NL7302385A (US07582779-20090901-C00044.png) 1973-08-24
US3758679A (en) 1973-09-11
FR2181747A1 (US07582779-20090901-C00044.png) 1973-12-07
GB1390311A (en) 1975-04-09
FR2181747B1 (US07582779-20090901-C00044.png) 1976-12-31
IL41527A0 (en) 1973-04-30
ATA151973A (de) 1975-09-15
ZA731154B (en) 1974-10-30
BE795766A (fr) 1973-08-22
IE37297L (en) 1973-08-22
DE2307747A1 (de) 1973-08-30
AU5222373A (en) 1974-08-15
HU165913B (US07582779-20090901-C00044.png) 1974-12-28
CA1016460A (en) 1977-08-30
IE37297B1 (en) 1977-06-22
DD102302A5 (US07582779-20090901-C00044.png) 1973-12-12
JPS4896716A (US07582779-20090901-C00044.png) 1973-12-10
AU473502B2 (en) 1976-06-24
AR195704A1 (es) 1973-10-31

Similar Documents

Publication Publication Date Title
AT330360B (de) Verfahren zur herstellung eines pharmazeutischen praparates
AT340228B (de) Verfahren zur herstellung eines verbundgegenstandes
AT336799B (de) Verfahren zur herstellung eines zahnpflegemittels
AT340686B (de) Verfahren zur herstellung eines polyelektrolyten
AT353415B (de) Verfahren zur herstellung eines pharma- zeutischen praeparates
AT342002B (de) Verfahren zur herstellung wasserunloslicher kapseln
AT337902B (de) Verfahren zur herstellung eines pharmazeutischen pulvers
AT330954B (de) Verfahren zur herstellung eines pharmazeutischen praparates
AT344327B (de) Verfahren zur herstellung eines rektal anwendbaren pharmazeutischen praeparates
AT329313B (de) Verfahren zur herstellung eines veterinarmedizinischen praparates
AT343284B (de) Verfahren zur herstellung eines kalorienarmen nahrungsmittels
AT327661B (de) Verfahren zur herstellung eines sauermilchpulvers
AT330349B (de) Verfahren zur herstellung eines ubertragungsfaktors
AT336176B (de) Verfahren zur herstellung eines pharmazeutischen praparates
CH525005A (de) Verfahren zur Herstellung eines pharmazeutischen oder diagnostischen Präparates
AT330962B (de) Verfahren zur herstellung eines praparates zur nasalen applikation
AT323910B (de) Verfahren zur herstellung eines neuen triamcinolonderivates
AT338412B (de) Verfahren zur herstellung eines pharmazeutischen praparates
AT344879B (de) Verfahren zur herstellung eines pharmazeutischen kombinationspraeparates
AT329743B (de) Verfahren zur herstellung eines praparates zur nasalen applikation
CH556859A (de) Verfahren zur herstellung eines triazolyl-naphthalimids.
ATA880673A (de) Verfahren zur herstellung eines pharmazeutischen praparates zur verbesserung der zellatmung
AT323682B (de) Verfahren zur herstellung eines backmittels
AT347172B (de) Verfahren zur herstellung eines tierheilmittels
AT312161B (de) Verfahren zur Herstellung eines pharmazeutischen Präparates

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties